On the molecular biology level, the effects of moxibustion against CKD may be associated with enhancing the expression of renal podocin and nephrin mRNA and increasing the level of podocyte marker protein in kidney tissue to alleviate kidney podocyte injury [20]. Here, NPHS2 is linked to chronic kidney disease.